Bain Capital Life Sciences Investors’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-915,000
| Closed | -$13.5M | – | 29 |
|
2023
Q3 | $13.5M | Sell |
915,000
-1,500,000
| -62% | -$22.2M | 1.51% | 17 |
|
2023
Q2 | $31.2M | Sell |
2,415,000
-1,500,000
| -38% | -$19.4M | 3.21% | 10 |
|
2023
Q1 | $38.4M | Hold |
3,915,000
| – | – | 4.8% | 6 |
|
2022
Q4 | $41.7M | Sell |
3,915,000
-1,500,000
| -28% | -$16M | 4.66% | 8 |
|
2022
Q3 | $56.5M | Sell |
5,415,000
-3,000,000
| -36% | -$31.3M | 6.75% | 5 |
|
2022
Q2 | $106M | Hold |
8,415,000
| – | – | 12.42% | 2 |
|
2022
Q1 | $91.2M | Hold |
8,415,000
| – | – | 8.86% | 2 |
|
2021
Q4 | $118M | Hold |
8,415,000
| – | – | 9.39% | 2 |
|
2021
Q3 | $162M | Sell |
8,415,000
-3,356,708
| -29% | -$64.5M | 10.03% | 2 |
|
2021
Q2 | $116M | Buy |
11,771,708
+875,935
| +8% | +$8.63M | 7.6% | 3 |
|
2021
Q1 | $107M | Hold |
10,895,773
| – | – | 6.07% | 4 |
|
2020
Q4 | $48.5M | Hold |
10,895,773
| – | – | 3.04% | 10 |
|
2020
Q3 | $47.1M | Hold |
10,895,773
| – | – | 4.39% | 7 |
|
2020
Q2 | $96.6M | Buy |
10,895,773
+2,165,066
| +25% | +$19.2M | 10.12% | 4 |
|
2020
Q1 | $30.8M | Buy |
8,730,707
+278,472
| +3% | +$983K | 5.21% | 5 |
|
2019
Q4 | $48.3M | Hold |
8,452,235
| – | – | 7.21% | 4 |
|
2019
Q3 | $30.3M | Buy |
+8,452,235
| New | +$30.3M | 7.79% | 5 |
|